Inactive Instrument

Other languages Quanta, Inc. Other OTC

Equities

QNTA

US74766N1081

Other languages

Unlock all the news: Be the first to know and act before the market!

Quanta and Medolife Rx Provide Updates on Activities and Plans	22-12-05
QUANTA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	22-08-17
QUANTA INC : Other Events (form 8-K)	22-06-27
QUANTA INC : Entry into a Material Definitive Agreement (form 8-K)	22-06-16
Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews	22-06-01
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-23
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions	22-05-04
QUANTA INC : Regulation FD Disclosure (form 8-K)	22-05-04
QUANTA INC : Changes in Registrant's Certifying Accountant (form 8-K)	22-04-28
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-04-15
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15
Medolife Rx Announces Changes to Management and Improvements to AELIA’s Marketing Efforts	22-02-07
Medolife Rx Announces Changes to Management and Improvements to AELIA’s Marketing Efforts	22-02-07
Medolife Rx Submits Final Clinical Trial Data for Escozine Approval as a COVID-19 Treatment in The Dominican Republic	22-01-19
Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic	22-01-11
Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products	21-12-02
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)	21-11-23
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-11-22
Quanta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Quanta, Inc. Other OTC

Equities

QNTA

US74766N1081

Other languages

Filters